<DOC>
	<DOCNO>NCT00182494</DOCNO>
	<brief_summary>Diabetes 2-5 time common schizophrenia preventable ; current diabetes prevention guideline suitable implementation severely mentally ill population . The principle diabetes prevention essentially dietary regulation , increase physical activity adjunctive use oral anti-diabetic drug ( metformin ) . In modified diabetes prevention protocol suitable use mentally ill population , package original guide line adventure recreation program base principle experiential learning , cognitive restructuring behaviour modification . In proposed study , plan evaluate feasibility adopt new protocol , examine effectiveness prevent diabetes .</brief_summary>
	<brief_title>Diabetes Prevention Program Schizophrenia DPPS</brief_title>
	<detailed_description>Rationale : - From large international RCT study , Type 2 Diabetes prevent / delay overweight , pre-diabetic individual make basic lifestyle change ( regular moderate exercise , healthy eat habit ) use metformin insulin resistance inhibitor . - Individuals schizophrenia particular need preventative intervention conventional approach match need . - Research examine facilitate lifestyle change live individual schizophrenia . We need to… - Develop evaluate innovative diabetes prevention strategy tailor meet need individual schizophrenia . - Research make work pre-diabetic individual treat schizophrenia . The effectiveness novel intervention test use prospective , randomize , control clinical trial . A multi-factorial design enable 2 x 2 analysis independent effect three intervention – tailor lifestyle modification program , metformin , standard conventional intervention . There anticipated interaction effect metformin lifestyle intervention . Clients currently treat schizophrenia community outpatient clinic screen diabetes , fulfill inclusion criterion , give write consent , follow three week run-in period , randomize one four group receive either : experimental intervention placebo , experimental intervention metformin conventional intervention placebo conventional intervention metformin .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>1 . People least 18 year old , diagnosed schizophrenia , confirm structured clinical interview ( SCIDP ) DSM IV , treat antipsychotic drug least 2 year deem clinically stable . Clinical stability operationally define absence relapse warrant hospitalization precede six month . 2 . People deem “ prediabetics ” accordance diagnostic criterion establish American Diabetic Association ( ADA , 2004 ) follow : impaired fasting glucose ( IFG ) indicate fast plasma glucose range 100125 mg/dl 5.6 6.9 mmol/l . ; impair glucose tolerance ( IGT ) indicate 2h postload glucose range 140199 mg/dl 7.8 11.0 mmol/l . 3 . People gain &gt; 10 % body weight since ? ? ? Or body mass index &gt; 24 kg/m² , except Asian decent 22 kg/m² great ? ? 4 . Competent provide inform consent voluntarily participate study . 1 . People meet criterion diabetes , ( i.e. , repeat fast blood glucose ( FBG ) &gt; 7 mmol/l , 2 hr . postload glucose &gt; 11.1 mmol . determine 2 hr . glucose tolerance test ( GTT ) ) . 2 . People evidence clinically significant liver disease , renal gastrointestinal impairment , suggest clinical history liver kidney function test . Any impairment deem clinically significant would relative contraindication use metformin . 3 . Women child bear age , willing use contraceptive measure . 4 . People comorbid disorder clinically significant heart lung disease may prevent participation various physical activity disorder glucose metabolism ( e.g. , Cushing ’ Syndrome , Acromegaly , chronic pancreatitis ) . 5 . People treatment would interfere participation completion protocol ( e.g. , share care plan discharge shortly clinic ) , confound effect measurement primary outcome study ( prescription weight loss drug , lipid lower agent ? ) 6 . People weight loss &gt; 10 % past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>Schizophrenia , Diabetes , Weight gain , Antipsychotic drug</keyword>
</DOC>